Literature DB >> 27734463

Is the revised International staging system for myeloma valid in a real world population?

Ieuan Walker1, Alice Coady1, Michael Neat2,3, Darius Ladon4, Reuben Benjamin5,6, Inas El-Najjar2,5, Majid Kazmi2,5, Steve Schey5,6, Matthew Streetly2,5,6.   

Abstract

Entities:  

Keywords:  classifications; multiple myeloma; myeloma; prognostic factors; risk factors

Mesh：

Year:  2016        PMID： 27734463     DOI： 10.1111/bjh.14341

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data.

Authors:  Adrián Mosquera Orgueira; Marta Sonia González Pérez; José Ángel Díaz Arias; Beatriz Antelo Rodríguez; Natalia Alonso Vence; Ángeles Bendaña López; Aitor Abuín Blanco; Laura Bao Pérez; Andrés Peleteiro Raíndo; Miguel Cid López; Manuel Mateo Pérez Encinas; José Luis Bello López; Maria Victoria Mateos Manteca
Journal:  Leukemia       Date:  2021-05-18       Impact factor: 11.528

2.  Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society.

Authors:  Yoshiaki Abe; Kazutaka Sunami; Takeshi Yamashita; Mikio Ueda; Hiroyuki Takamatsu; Kentaro Narita; Hiroki Kobayashi; Akihiro Kitadate; Masami Takeuchi; Kosei Matsue
Journal:  Oncotarget       Date:  2019-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.